Smith Shellnut Wilson LLC Bristol Myers Squibb CO Transaction History

Smith Shellnut Wilson LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $5,085 - $5,766	-106 Reduced 1.96%	5,299 $287,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $6,463 - $7,118	-89 Reduced 1.62%	5,405 $416,000
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $48,630 - $58,312	-791 Reduced 12.59%	5,494 $401,000
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $7,025 - $8,190	131 Added 2.13%	6,285 $392,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $127,807 - $149,709	2,160 Added 54.08%	6,154 $364,000
Q1 2021 Apr 06, 2021	SELL	$59.34 - $66.74 $7,773 - $8,742	-131 Reduced 3.18%	3,994 $252,000
Q2 2020 Aug 26, 2020	BUY	$54.82 - $64.09 $16,610 - $19,419	303 Added 7.93%	4,125 $243,000
Q1 2020 Apr 20, 2020	BUY	$46.4 - $67.43 $28,768 - $41,806	620 Added 19.36%	3,822 $213,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $157,570 - $205,536	3,202 New	3,202 $206,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Smith Shellnut Wilson LLC , based on Form 13F filings with the SEC.

Stay updated on Smith Shellnut Wilson LLC with notifications on news.